HIV protease inhibitors block streptolysin S production.

PubWeight™: 0.83‹?›

🔗 View Article (PMID 25668590)

Published in ACS Chem Biol on February 20, 2015

Authors

Tucker Maxson1, Caitlin D Deane1,2, Evelyn M Molloy2, Courtney L Cox2,3, Andrew L Markley4, Shaun W Lee5, Douglas A Mitchell1,2,3

Author Affiliations

1: †Department of Chemistry, University of Illinois at Urbana-Champaign, Urbana, Illinois, United States.
2: ‡Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, Illinois, United States.
3: §Department of Microbiology, University of Illinois at Urbana-Champaign, Urbana, Illinois, United States.
4: ∥Department of Biological Sciences, Eck Institute for Global Health, University of Notre Dame, Notre Dame, Indiana, United States.
5: ⊥Department of Chemical and Biological Engineering, University of Wisconsin-Madison, Madison, Wisconsin, United States.

Articles cited by this

Pathogenesis of group A streptococcal infections. Clin Microbiol Rev (2000) 15.35

The global burden of group A streptococcal diseases. Lancet Infect Dis (2005) 13.58

Bacteriocins of gram-positive bacteria. Microbiol Rev (1995) 7.68

Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclature. Nat Prod Rep (2013) 5.38

Biosynthesis and mode of action of lantibiotics. Chem Rev (2005) 4.59

Anti-virulence strategies to combat bacteria-mediated disease. Nat Rev Drug Discov (2010) 4.23

Formation of a bacterial toxin (streptolysin S) by resting cells. J Exp Med (1949) 4.09

Streptococcal toxins (streptolysin O, streptolysin S, erythrogenic toxin). Pharmacol Ther (1980) 4.08

The biology and future prospects of antivirulence therapies. Nat Rev Microbiol (2008) 3.83

Discovery of a widely distributed toxin biosynthetic gene cluster. Proc Natl Acad Sci U S A (2008) 3.20

SPOCTOPUS: a combined predictor of signal peptides and membrane protein topology. Bioinformatics (2008) 3.20

Follow the leader: the use of leader peptides to guide natural product biosynthesis. Nat Chem Biol (2010) 3.16

Thiopeptide antibiotics. Chem Rev (2005) 2.59

Genetic locus for streptolysin S production by group A streptococcus. Infect Immun (2000) 2.52

Reduced virulence of group A streptococcal Tn916 mutants that do not produce streptolysin S. Infect Immun (1998) 2.44

Mutational analysis of the group A streptococcal operon encoding streptolysin S and its virulence role in invasive infection. Mol Microbiol (2005) 2.30

An epidemic of pharyngitis due to a nonhemolytic group A streptococcus at lowry air force base. N Engl J Med (1971) 2.19

Viracept (nelfinavir mesylate, AG1343): a potent, orally bioavailable inhibitor of HIV-1 protease. J Med Chem (1997) 2.04

Cyanobactins-ribosomal cyclic peptides produced by cyanobacteria. Appl Microbiol Biotechnol (2010) 1.79

Thiazole/oxazole-modified microcins: complex natural products from ribosomal templates. Curr Opin Chem Biol (2011) 1.67

An extracellular bacterial pathogen modulates host metabolism to regulate its own sensing and proliferation. Cell (2014) 1.61

Absence of the CAAX endoprotease Rce1: effects on cell growth and transformation. Mol Cell Biol (2002) 1.56

Type II CAAX prenyl endopeptidases belong to a novel superfamily of putative membrane-bound metalloproteases. Trends Biochem Sci (2001) 1.55

Listeriolysin S, a novel peptide haemolysin associated with a subset of lineage I Listeria monocytogenes. PLoS Pathog (2008) 1.53

YcaO domains use ATP to activate amide backbones during peptide cyclodehydrations. Nat Chem Biol (2012) 1.50

The structural basis of ZMPSTE24-dependent laminopathies. Science (2013) 1.43

Streptolysin S-like virulence factors: the continuing sagA. Nat Rev Microbiol (2011) 1.42

Some HIV protease inhibitors alter lamin A/C maturation and stability, SREBP-1 nuclear localization and adipocyte differentiation. AIDS (2003) 1.40

Physical behavior of streptolysin S. J Bacteriol (1967) 1.33

Structure determination and interception of biosynthetic intermediates for the plantazolicin class of highly discriminating antibiotics. ACS Chem Biol (2011) 1.27

Clostridiolysin S, a post-translationally modified biotoxin from Clostridium botulinum. J Biol Chem (2010) 1.25

HIV protease inhibitors block the zinc metalloproteinase ZMPSTE24 and lead to an accumulation of prelamin A in cells. Proc Natl Acad Sci U S A (2007) 1.20

Studies with recombinant Saccharomyces cerevisiae CaaX prenyl protease Rce1p. Biochemistry (2000) 1.18

Lasso peptides: structure, function, biosynthesis, and engineering. Nat Prod Rep (2012) 1.15

Insights into the mechanism of peptide cyclodehydrations achieved through the chemoenzymatic generation of amide derivatives. J Am Chem Soc (2013) 1.11

The abi proteins and their involvement in bacteriocin self-immunity. J Bacteriol (2010) 1.08

Mechanism of farnesylated CAAX protein processing by the intramembrane protease Rce1. Nature (2013) 1.05

Insights into the broad cellular effects of nelfinavir and the HIV protease inhibitors supporting their role in cancer treatment and prevention. Curr Opin Oncol (2013) 1.03

Combined contributions of streptolysin O and streptolysin S to virulence of serotype M5 Streptococcus pyogenes strain Manfredo. Infect Immun (2003) 1.02

Mutational analysis of the ras converting enzyme reveals a requirement for glutamate and histidine residues. J Biol Chem (2005) 1.01

A potent HIV protease inhibitor, darunavir, does not inhibit ZMPSTE24 or lead to an accumulation of farnesyl-prelamin A in cells. J Biol Chem (2008) 0.99

Orchestration of enzymatic processing by thiazole/oxazole-modified microcin dehydrogenases. Biochemistry (2014) 0.98

Expansion of type II CAAX proteases reveals evolutionary origin of γ-secretase subunit APH-1. J Mol Biol (2011) 0.97

Real-time PCR assay to differentiate Listeriolysin S-positive and -negative strains of Listeria monocytogenes. Appl Environ Microbiol (2010) 0.95

Nonhemolytic Streptococcus pyogenes isolates that lack large regions of the sag operon mediating streptolysin S production. J Clin Microbiol (2009) 0.84

Genetic analyses of the role of RCE1 in RAS membrane association and transformation. Methods Enzymol (2008) 0.83

An Escherichia coli-based bioengineering strategy to study streptolysin S biosynthesis. Anal Biochem (2011) 0.76